Release Date: 19/08/14 17:34 Summary: Change in substantial holding from MTE Price Sensitive: No Download Document 233.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%